FINWIRES · TerminalLIVE
FINWIRES

Research Alert: CFRA Maintains Buy Opinion On Shares Of Dell Technologies Inc

By

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

We increase our price target by $24 to $263, 17.5x our FY 28 (Jan.) EPS view, above DELL's three-year average (~11x) as significant demand from the AI buildout offsets PC weakness and temporary supply/margin risks. We lift our FY 27 EPS view by $0.15 to $12.95 and raise FY 28's by $0.14 to $15.05. As Q1 earnings have progressed, all signs point to better-than-expected demand for all things AI, validated by continued increases in hyperscalers' capex projections and improving projections across semis/semi equip. We also see upside associated with comments from President Trump last Friday to "go out and buy a Dell" (sending shares up 13% on the day), which we doubt moves the needle much on the PC business but which we think signals a further divergence in reputation between DELL and server peer SMCI (amid associated export control violations), further solidifying our position that customer demand and priority supply allocations (of GPUs and memory) will shift towards DELL/HPE, creating incremental demand.

Related Articles

Research

Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Applied Materials, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our price target by $72 to $533, 32x our FY 27 (Oct.) EPS view, near peers and above AMAT's three-year average (~20x) as AI tailwinds structurally improve demand growth and visibility. We raise our FY 26 EPS view by $0.96 to $12.10, lift FY 27 by $2.25 to $16.65, and initiate FY 28 at $21.95. Q2 earnings brought a significantly improved outlook, with AMAT now expecting 30%+ Semi Segment revenue growth in CY 26 (a confident step-up from last quarter's projection of 20%+ for the year) along with a normalized mid-teens growth rate for AGS (up from a low-teens view), all supported by incremental demand improvement in Q2 from already impressive levels. Customers are reportedly adding new cleanroom space at a faster-than-expected pace (and widely providing 8-quarter demand forecasts), while AMAT's supply chain is not expected to be a constraint this year, which is not the case for all WFE peers. China sales (27% of total, -300 bps Q/Q) look to have stabilized, providing less of a headwind to overall growth.

$AMAT
Research

Research Alert: CFRA Lowers View On Shares Of American Express Company To Buy From Strong Buy

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our 12-month target price by $40 to $410, applying a forward P/E of 20.3x our 2027 earnings estimate, a wider risk premium than the peer average of 7.4x given more consistent earnings performance. We lower our 2026 EPS estimate by $0.17 to $17.78 and reduce 2027's by $0.23 to $20.20. We have become more cautious primarily due to macroeconomic factors. The prolonged Middle East conflict has caused U.S. real wage growth to turn negative for the first time in three years. Despite this, AXP remains the best-in-class credit card issuer, and we expect competitors to face more of a strain on credit quality. Importantly, we are confident that credit card interest rate caps, a concern earlier this year, will not be implemented. Additionally, the Platinum Card refresh should continue to drive strong fee growth, with the annual fee increased to $895 from $695. Significant growth opportunities exist in international markets where market share is still minimal.

$AXP
Research

Research Alert: CFRA Maintains Sell Opinion On Shares Of Starbucks Corporation

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:SBUX announced layoffs and plans to close non-retail support facilities, expecting $400M of FY 26 (Sep.) restructuring charges: $280M non-cash impairment (Reserve/Roastery locations, support facilities) and $120M cash severance. This continues the 'Back to Starbucks' $2B cost savings plan. While we view cost discipline positively, we maintain our Sell rating and 12-month price target of $82 (30x FY 27 EPS). At $108, shares trade at 40x NTM P/E, embedding a sustained SSS recovery we believe is at risk as comparisons normalize in 2H. Recent SSS strength exceeded estimates, but SBUX is lapping historically weak periods. Q2's margin expansion was encouraging, though we attribute much of the improvement to China JV accounting rather than core operations. Today's restructuring does not alter our view that valuation remains stretched with 24% downside to our target. We would revisit our rating on SSS durability through tougher compares or material multiple compression.

$SBUX